newsfilter
← Latest News
GlobeNewswire·

TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the TD Cowen Immunology